Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.09 USD | -2.49% | -6.78% | +24.75% |
Jul. 01 | Sana Biotechnology, Inc.(NasdaqGS:SANA) dropped from Russell Small Cap Comp Value Index | CI |
Jul. 01 | Sana Biotechnology, Inc.(NasdaqGS:SANA) dropped from Russell 3000 Value Index | CI |
Business Summary
Number of employees: 328
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Shanna Peek
COO | Chief Operating Officer | - | 19-06-30 |
Edward Rebar
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-02-29 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-10-31 |
Ke Liu
LAW | General Counsel | - | 21-01-05 |
Sonja Schrepfer
PRN | Corporate Officer/Principal | 49 | 19-01-31 |
Steven Goldman
PRN | Corporate Officer/Principal | 66 | 20-09-30 |
Terry Fry
PRN | Corporate Officer/Principal | 57 | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Douglas Cole
BRD | Director/Board Member | 63 | 20-03-31 |
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Josh Bilenker
BRD | Director/Board Member | 52 | 21-01-07 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-10-31 |
Hans Bishop
FOU | Founder | 59 | 18-07-12 |
Michelle Seitz
BRD | Director/Board Member | 59 | 20-11-30 |
Alise Reicin
BRD | Director/Board Member | 63 | 20-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 221,502,908 | 202,379,939 ( 91.37 %) | 0 | 91.37 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.75% | 1.13B | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- SANA Stock
- Company Sana Biotechnology, Inc.